Innovative HBV Animal Models Based on the Entry Receptor NTCP
Open Access
Abstract
Hepatitis B is a major global health problem, with an estimated 257 million chronically infected patients and almost 1 million deaths per year. The causative agent is hepatitis B virus (HBV), a small, enveloped, partially double-stranded DNA virus. HBV has a strict species specificity, naturally infecting only humans and chimpanzees. Sodium taurocholate co-transporting polypeptide (NTCP), a bile acid transporter expressed on hepatocytes, has been shown to be one of the key factors in HBV infection, playing a crucial role in the HBV entry process in vitro and in vivo. Variations in the amino acid sequence of NTCP can inhibit HBV infection and, therefore, contributes, in part, to the species barrier. This discovery has revolutionized the search for novel animal models of HBV. Indeed, it was recently shown that variations in the amino acid sequence of NTCP represent the sole species barrier for HBV infection in macaques. Here, we review what is known about HBV entry through the NTCP receptor and highlight how this knowledge has been harnessed to build new animal models for the study of HBV pathogenesis and curative therapies.Keywords
This publication has 71 references indexed in Scilit:
- A New Class of Synthetic Peptide Inhibitors Blocks Attachment and Entry of Human Pathogenic VirusesThe Journal of Infectious Diseases, 2012
- A Humanized Mouse Model to Study Hepatitis C Virus Infection, Immune Response, and Liver DiseaseGastroenterology, 2011
- Fine Mapping of Pre-S Sequence Requirements for Hepatitis B Virus Large Envelope Protein-Mediated Receptor InteractionJournal of Virology, 2010
- The Size of the Viral Inoculum Contributes to the Outcome of Hepatitis B Virus InfectionJournal of Virology, 2009
- Repopulation of adult and neonatal mice with human hepatocytes: A chimeric animal modelProceedings of the National Academy of Sciences, 2007
- Hepatitis B virus infection initiates with a large surface protein–dependent binding to heparan sulfate proteoglycansHepatology, 2007
- Lipid-Mediated Introduction of Hepatitis B Virus Capsids into Nonsusceptible Cells Allows Highly Efficient Replication and Facilitates the Study of Early Infection EventsJournal of Virology, 2006
- Mapping of the Hepatitis B Virus Pre-S1 Domain Involved in Receptor RecognitionJournal of Virology, 2005
- Mapping of the Hepatitis B Virus Attachment Site by Use of Infection-Inhibiting preS1 Lipopeptides and Tupaia HepatocytesGastroenterology, 2005
- Cholestatic Expression Pattern of Sinusoidal and Canalicular Organic Anion Transport Systems in Primary Cultured Rat HepatocytesHepatology, 2001